Eberhard Karls Universität Tübingen

X-ray counterpart detection and γ-ray analysis of the supernova remnant G279.0+01.1 with eROSITA and Fermi-LAT (2024) Michailidis M, Pühlhofer G, Santangelo A, Becker W, Sasaki M Journal article Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors (2024) Ruf T, Kramer R, Forschner A, Leiter U, Meier F, Reinhardt L, Dücker P, et al. Journal article Genetic landscape of pediatric acute liver failure of indeterminate origin. (2024) Lenz D, Schlieben LD, Shimura M, Bianzano A, Smirnov D, Kopajtich R, Berutti R, et al. Journal article, Original article Efficacy of Physical Activity Promoting Interventions in Physical Therapy and Exercise Therapy for Persons with Noncommunicable Diseases: An Overview of Systematic Reviews (2024) Jung A, Geidl W, Matting L, Hoessel LM, Siemens W, Sudeck G, Pfeifer K Journal article Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IB (2024) Amaral T, Nanz L, Stadler R, Berking C, Ulmer A, Forschner A, Meiwes A, et al. Journal article Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2024) Maffini E, Labopin M, Kröger N, Finke J, Stelljes M, Schroeder T, Einsele H, et al. Journal article eROSITA studies of the Carina nebula (2024) Sasaki M, Robrade J, Krause MG, Knies J, Tsuge K, Pühlhofer G, Strong A Journal article Mott transition and pseudogap of the square-lattice Hubbard model: Results from center-focused cellular dynamical mean-field theory (2024) Meixner M, Menke H, Klett M, Heinzelmann S, Andergassen S, Hansmann P, Schäfer T Journal article The SRG/eROSITA all-sky survey: First X-ray catalogues and data release of the western Galactic hemisphere (2024) Merloni A, Lamer G, Liu T, Ramos-Ceja ME, Brunner H, Bulbul E, Dennerl K, et al. Journal article Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer (2024) Fasching P, Decker T, Hartkopf A, Nusch A, Heinrich BJ, Kurbacher C, Fuchs R, et al. Journal article